US EditionPublished • loading... • Updated
Mitria Medical’s Subvalvular Spacer implanted under compassionate use
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mitria Medical’s Subvalvular Spacer implanted under compassionate use
Mitria Medical has announced the first implantation of its novel Subvalvular Spacer (SVS) in the USA under the US Food and Drug Administration (FDA) single patient expanded access programme. Also known as “compassionate use”, this designation allows a patient with a serious, immediately life-threatening condition to access an investigational medical product outside of clinical trials when no satisfactory alternative options are available. The pr…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
